Exact Sciences Corp
(NASDAQ:EXAS)
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
top performing EXAS trades
5.70%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Exact Sciences trades made by congress members.
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Jun 08, 2024 | May 10, 2024 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale (Partial) | Mar 07, 2024 | Feb 01, 2024 | House |
Kevin HernHouse (R-OK) | $1K - $15K | stock | Sale | Feb 11, 2024 | Jan 02, 2024 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Dec 08, 2023 | Nov 13, 2023 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Nov 11, 2023 | Oct 16, 2023 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale (Partial) | Oct 15, 2023 | Sep 15, 2023 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Jun 11, 2023 | May 01, 2023 | House |
Kevin HernHouse (R-OK) | $1K - $15K | stock | Sale | Feb 14, 2023 | Jan 31, 2023 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Feb 17, 2023 | Jan 20, 2023 | House |
Kevin HernHouse (R-OK) | $50K - $100K | stock | Sale | Jan 13, 2023 | Dec 19, 2022 | House |
Kevin HernHouse (R-OK) | $1K - $15K | stock | Sale | Jun 14, 2022 | May 16, 2022 | House |